Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (11321)	8/17/1999 12:10:00 PM
From: Bluegreen	Respond to of 17367

Cacaito, I hope you will still participate on the board even though you have sold out. In my opinion, smart money is buying big time. I try not to fight the smart money. Think about it, the game is to make money not playing into idiotic news releases. Never in my wildest dreams did I think the FDA would approve without detailed analysis. Especially for this complicated indication. If data was bad why did the DSMB allow Xoma to continue and who was it that gave the okay to end trial without completely fulfilling the mortality requirement? Good luck in your future investments!